Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]
Home »

HEART-FID: Is Intravenous Ferric Carboxymaltose Helpful in HFrEF With Iron Deficiency?

Sep 05, 2023

REFERENCES & ADDITIONAL READING

Kalra PR, et al. Lancet. 2022;400(10369):2199–2209.

Mentz RJ, et al. The HEART-FID trial: efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency. Hot Line 2, ESC Congress 2023, 25–28 August, Amsterdam, the Netherlands.

Ponikowski P, et al. Lancet. 2020;396(10266):1895–1904.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

RELEVANT ARTICLES FOR YOU

Advertisement
[adinserter block="6" template="Article Pages" check="exceptions" ignore="page-type"]